Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Q Bernardini

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|May 28, 2011
Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancerBrigitte L Thériault, Sanja Pajovic, Marcus Q Bernardini, et al.
Journal of Robotic Surgery|July 18, 2016
Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic reviewImmaculate F Nevis, Bahareh Vali, Caroline Higgins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 28, 2024
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with <i>BRCA</i> mutated advanced high grade serous ovarian cancer: 10 year survival analysisSoyoun Rachel Kim, Ashna Parbhakar, Xuan Li, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 22, 2017
A Multicentre Retrospective Review of Clinical Characteristics of Uterine SarcomaMarta Wais, Elissa Tepperman, Marcus Q Bernardini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysisSoyoun Rachel Kim, Ashna Parbhakar, Xuan Li, et al.
Journal of Ovarian Research|December 22, 2014
The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cellsBrigitte L Thériault, Paulina Cybulska, Patricia A Shaw, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 2, 2021
Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancerSoyoun Rachel Kim, Manjula Maganti, Marcus Q Bernardini, et al.
Theranostics|May 28, 2019
Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancerLauren Philp, Harley Chan, Marjan Rouzbahman, et al.
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
F1000Research|July 10, 2018
Unraveling endometriosis-associated ovarian carcinomas using integrative proteomicsFelix Leung, Marcus Q Bernardini, Kun Liang, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|May 28, 2011
Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancerBrigitte L Thériault, Sanja Pajovic, Marcus Q Bernardini, et al.
Journal of Robotic Surgery|July 18, 2016
Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic reviewImmaculate F Nevis, Bahareh Vali, Caroline Higgins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 28, 2024
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with <i>BRCA</i> mutated advanced high grade serous ovarian cancer: 10 year survival analysisSoyoun Rachel Kim, Ashna Parbhakar, Xuan Li, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 22, 2017
A Multicentre Retrospective Review of Clinical Characteristics of Uterine SarcomaMarta Wais, Elissa Tepperman, Marcus Q Bernardini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysisSoyoun Rachel Kim, Ashna Parbhakar, Xuan Li, et al.
Journal of Ovarian Research|December 22, 2014
The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cellsBrigitte L Thériault, Paulina Cybulska, Patricia A Shaw, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 2, 2021
Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancerSoyoun Rachel Kim, Manjula Maganti, Marcus Q Bernardini, et al.
Theranostics|May 28, 2019
Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancerLauren Philp, Harley Chan, Marjan Rouzbahman, et al.
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
F1000Research|July 10, 2018
Unraveling endometriosis-associated ovarian carcinomas using integrative proteomicsFelix Leung, Marcus Q Bernardini, Kun Liang, et al.
Pageof 13